Globus Medical, Inc.
GMED
Rang in aandelen
#1984
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Aandeelprijs
$79.05
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$10.61B
Verandering (1 dag)
4.29%
Verandering (1 jaar)
26.02%
Land
US
Handel Globus Medical, Inc. (GMED)
Categorie
Healthcare
Winst voor Globus Medical, Inc. (GMED)
Winst in Jun 2026 TTM: $664.95M
Volgens de meest recente financiële verslagen van Globus Medical, Inc. bedraagt de huidige winst van het bedrijf $664.95M. In 2023 behaalde het bedrijf een winst van $165.39M, een daling ten opzichte van de winst van 2022, die $243.02M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Globus Medical, Inc. van 2009 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $664.95M | 450.81% |
| 2024 | $120.72M | -27.01% |
| 2023 | $165.39M | -31.94% |
| 2022 | $243.02M | 34.71% |
| 2021 | $180.41M | 43.30% |
| 2020 | $125.90M | -33.72% |
| 2019 | $189.95M | 0.71% |
| 2018 | $188.61M | 10.99% |
| 2017 | $169.93M | 8.04% |
| 2016 | $157.28M | -8.98% |
| 2015 | $172.81M | 24.64% |
| 2014 | $138.64M | 35.92% |
| 2013 | $102.00M | -11.04% |
| 2012 | $114.65M | 18.26% |
| 2011 | $96.95M | 10.50% |
| 2010 | $87.74M | 7.29% |
| 2009 | $81.78M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.51B | 1,029.56% |
US
|
|
| $5.56B | 736.60% |
IE
|
|
| $5.15B | 674.19% |
US
|
|
| $3.86B | 480.65% |
US
|
|
| - | - |
DE
|
